Welcome to the Treating CD30+ Lymphoma Platform

Welcome, this website is intended for healthcare professionals with an interest in the treatment of lymphoma. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Dr Martin Hutchings

 Dr Martin Hutchings is a clinical oncologist and a staff specialist from the Department of Haematology, Rigshospitalet, Copenhagen University Hospital.

After obtaining his medical degree and master’ degree (2000), he trained in nuclear medicine until pursuing his current specialisation in clinical oncology. In 2006, he defended his PhD on PET and PET/CT in Hodgkin lymphoma.

Dr Hutchings acts as chairman of the EORTC Lymphoma Group's Scientific Steering Committee. He is currently involved in a number of observational clinical studies of PET/CT in lymphoma and is responsible for the central EORTC PET review for the EORTC/GELA/FIL H10 early stage Hodgkin lymphoma trial. He is the principal investigator for the EORTC H11 randomised trial on very early PET-response adapted therapy of advanced stage Hodgkin lymphoma.

Dr Hutchings has written numerous journal articles and book chapters on the role of PET/CT in Hodgkin and non-Hodgkin lymphomas and is engaged in a range of clinical research activities centred around his specialism in lymphoma treatment and research.